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Preclinical evidence, like clinical evidence, is used to inform
decisions about the safety and efficacy of treatments for
participants in clinical trials.[1] Unlike clinical studies, most
preclinical animal studies are not systematically reviewed, even
though systematic reviews of preclinical animal studies can
contribute significantly to creating more transparency regarding the
possible translation from preclinical animal studies to clinical
trials.[2][3][4][5][6] The expected benefits of systematic reviews of
preclinical animal studies encompass stimulating better science
and improving translation. Fewer than 250 systematic reviews of
preclinical animal studies were published prior to 2010, whereas
almost 6000 Cochrane Reviews have been published to date.
The quality of methodology and reporting of preclinical animal
studies is currently inadequate,[1][7][8][9] and the use of quality
and risk of bias assessments in systematic reviews has contributed
to the exposure of this problem.[1][10] Few preclinical animal
studies report the use of randomisation, allocation concealment,
blinding of personnel, or blind assessments of outcomes.[11] To
improve reporting for preclinical animal studies, guidelines have
been developed and are being implemented by journals and
publishers.[12][13] Another problem is that negative results are
often not published, leading to publication bias,[7] blurring the
interpretation and validity of the research findings.[14] Even though
the current situation identifies serious shortcomings in primary
studies, there are examples that demonstrate the value of
systematic reviews.[2][4][8][15] One unique challenge with animal
studies is the large amount of heterogeneity between studies.
Systematic reviews andmeta-analysis help to make heterogeneity
transparent, creating clues for causative factors and possible
mechanisms, and new hypotheses,[15] and practical methods
already exist for exploring this heterogeneity within meta-analysis
of preclinical systematic reviews.[16]
Systematic reviews andmeta-analyses of preclinical animal studies
create an overview of what has been published and how, including
judgements on possible translation.[1][2][3][4][5][6][8] Based on
systematic reviews of preclinical animal studies, Horn and
colleagues found no evidence to justify the start of clinical trials of
nimodipine for focal cerebral ischaemia in humans.[2] However, this
review was conducted after 7665 patients participated in clinical
trials and a Cochrane Review with the same conclusion was
published a year earlier.[17] Similarly, Pound and colleagues
demonstrated that drug side effects (excess risk of intracranial
hemorrhage after thrombolysis treatment for acute stroke) found
during the clinical trial could have been identified beforehand if a
systematic review of preclinical animal studies had been
performed.[4] There are also examples showing that reliance on
narrative reviews of preclinical animal studies to justify the start of
clinical trials in humans can bemisplaced.[8][18] Therefore,
systematic reviews of preclinical animal studies carried out prior to
the start of clinical trials can save resources and can lead to
improved safety for participants in clinical trials, and ultimately
better health care.
For all these reasons, a small but growing international community
of researchers is conducting systematic reviews of preclinical
animal studies. The Collaborative Approach to Meta Analysis and
Review of Animal Data from Experimental Studies (CAMARADES;
www.camarades.info) and the Systematic Review Centre for
Laboratory animal Experimentation (SYRCLE; www.SYRCLE.nl) are
at the forefront. CAMARADES is routinely performing systematic
reviews of preclinical animal studies in stroke and other
neurological disorders and has formed a worldwide network.
SYRCLE has focussed on the development of methodology and
guidelines and offers teaching and training internationally, in
addition to performing collaborative systematic reviews. SYRCLE
took the initiative for the first international symposium on
systematic reviews in laboratory animal science (Nijmegen, 2012),
and the second international symposium was organised by
CAMARADES in cooperation with SYRCLE (Edinburgh, 2013). The
conclusion from these meetings is that more systematic reviews of
preclinical animal studies are urgently needed. Moreover, much
more effort is needed in the field of education, and good reporting
and conduct of systematic reviews, in order to achieve more high-
quality systematic reviews.
For conducting preclinical systematic reviews, Cochrane
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methodology was the starting point and it has been transformed to
be specifically for preclinical animal studies. A number of tools have
been developed such as the search guide,[19] search
filters,[20][21][22] meta-analysis methods,[16] reporting guidelines
for preclinical systematic reviews,[23] and risk of bias
assessment.[24] Although good progress has been made, methods
and tools still need to be developed and improved upon for the
conduct of systematic reviews in preclinical animal studies. In
addition, muchmore education, teaching, and training is necessary
because animal researchers have little or no training in systematic
review methodology. For further development of tools, methods,
education and guidelines an animal methods group would be the
way forward.
During the Cochrane Colloquium in Quebec City, Canada
(September 2013), SYRCLE organised a workshop and special
meeting, with the aim to discuss the value of systematic reviews of
preclinical animal studies and their potential relevance to
Cochrane. There was overall endorsement for starting an official
methods group on systematic reviews of preclinical animal studies
in an international collaborative network. The proposedmethods
group would focus on developingmethods for the systematic
review of preclinical animal studies, improving the quality of
primary preclinical animal studies, and improving the translation
from preclinical and clinical trials.
With the establishment of a preclinical animal study methods group
in close co-operation with Cochrane, we hope to further advocate
the need for and promote the preparation of systematic reviews of
preclinical animal studies to aid making better well-informed
decisions about health care. Anyone interested in this methods
groupmay contact the first author.
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